Research reveals clinical trial candidate for those with genetic risk — ScienceDaily

A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration may be a potential candidate for an Alzheimer’s disease treatment for those who are at genetic risk, according to findings published in Nature Aging. The research included analysis showing that those who…

Click here to view the original article.